Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
271980.KS Stock Summary
Top 10 Correlated ETFs
271980.KS
In the News
271980.KS Financial details
Company Rating
Neutral
Market Cap
246.26B
Income
5B
Revenue
726.39B
Book val./share
10882.2
Cash/share
2447.07
Dividend
50
Dividend %
0.29%
Employees
973
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
82.03
Forward P/E
-
PEG
-6.15
P/S
0.35
P/B
1.52
P/C
6.82
P/FCF
-6.86
Quick Ratio
0.62
Current Ratio
1.01
Debt / Equity
0.54
LT Debt / Equity
0.03
-
-
EPS (TTM)
343.33
EPS next Y
-
EPS next Q
-
EPS this Y
-133.36%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
1.59%
Revenue Q/Q
1.39%
EPS Q/Q
-45.58%
-
-
-
-
SMA20
0.33%
SMA50
-1.02%
SMA100
11.13%
Inst Own
-
Inst Trans
-
ROA
1%
ROE
2%
ROC
0.03%
Gross Margin
25%
Oper. Margin
1%
Profit Margin
-
Payout
-
Shs Outstand
14.57M
Shs Float
14.44M
-
-
-
-
Target Price
-
52W Range
14540.0-22800.0
52W High
-26.75%
52W Low
+14.86%
RSI
48
Rel Volume
0.8
Avg Volume
11.3K
Volume
9.01K
Perf Week
-1.24%
Perf Month
-0.24%
Perf Quarter
3.66%
Perf Half Y
2.2%
-
-
-
-
Beta
1.145
-
-
Volatility
114.61%, 190.22%
Prev Close
-0.6%
Price
16700
Change
-1.42%
271980.KS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 45.77K | 47.3K | 47.97K | 49.54K | 49.85K | |
Net income per share | -721.53 | 473.24 | -1.03K | -1.03K | 343.46 | |
Operating cash flow per share | 1.97K | -1.3K | 1.31K | -1.04K | -341.81 | |
Free cash flow per share | 1.88K | -1.5K | 938.51 | -2.2K | -998.97 | |
Cash per share | 921.63 | 450.79 | 1.92K | 2.17K | 2.45K | |
Book value per share | 11.59K | 11.8K | 11.52K | 10.83K | 10.88K | |
Tangible book value per share | 11.3K | 11.52K | 11.2K | 10.03K | 9.89K | |
Share holders equity per share | 11.59K | 11.8K | 11.52K | 10.83K | 10.88K | |
Interest debt per share | 2.29K | 3.45K | 2.9K | 3.66K | 6.24K | |
Market cap | 531.04B | 914.87B | 494.4B | 324.36B | 258.21B | |
Enterprise value | 549.95B | 960.28B | 508.79B | 343.26B | 310.18B | |
P/E ratio | -50.17 | 132.28 | -32.99 | -21.61 | 51.59 | |
Price to sales ratio | 0.79 | 1.32 | 0.71 | 0.45 | 0.36 | |
POCF ratio | 18.34 | -48.03 | 25.88 | -21.41 | -51.84 | |
PFCF ratio | 19.27 | -41.75 | 36.07 | -10.1 | -17.74 | |
P/B Ratio | 3.12 | 5.31 | 2.94 | 2.05 | 1.63 | |
PTB ratio | 3.12 | 5.31 | 2.94 | 2.05 | 1.63 | |
EV to sales | 0.82 | 1.39 | 0.73 | 0.48 | 0.43 | |
Enterprise value over EBITDA | 63.47 | 41.55 | 145.5 | -72.83 | 16.63 | |
EV to operating cash flow | 18.99 | -50.42 | 26.64 | -22.66 | -62.28 | |
EV to free cash flow | 19.95 | -43.82 | 37.12 | -10.69 | -21.31 | |
Earnings yield | -0.02 | 0.01 | -0.03 | -0.05 | 0.02 | |
Free cash flow yield | 0.05 | -0.02 | 0.03 | -0.1 | -0.06 | |
Debt to equity | 0.19 | 0.29 | 0.24 | 0.32 | 0.54 | |
Debt to assets | 0.08 | 0.12 | 0.09 | 0.11 | 0.17 | |
Net debt to EBITDA | 2.18 | 1.96 | 4.12 | -4.01 | 2.79 | |
Current ratio | 1.27 | 1.27 | 1.28 | 1.09 | 1 | |
Interest coverage | 0.87 | 12.04 | -2.87 | -4.43 | 1.47 | |
Income quality | -2.74 | -2.73 | -1.27 | 1.01 | -1 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | -0.08 | 0.15 | -0.07 | -0.06 | 0.15 | |
Sales general and administrative to revenue | 0.04 | 0.03 | 0.04 | 0.04 | 0.05 | |
Research and developement to revenue | 0.03 | 0.04 | 0.06 | 0.06 | 0.06 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.02 | 0.03 | |
Capex to operating cash flow | -0.05 | 0.15 | -0.28 | 1.12 | 1.92 | |
Capex to revenue | 0 | 0 | -0.01 | -0.02 | -0.01 | |
Capex to depreciation | -0.18 | -0.32 | -0.59 | -1.91 | -0.98 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 13.72K | 11.21K | 16.31K | 15.84K | 9.17K | |
ROIC | 0.06 | 0.03 | -0.03 | -0.07 | 0.14 | |
Return on tangible assets | -0.03 | 0.02 | -0.04 | -0.03 | 0.01 | |
Graham Net | -3.7K | -3.97K | -4.67K | -7.06K | -7.9K | |
Working capital | 55.61B | 59.45B | 62.73B | 22.98B | -1.12B | |
Tangible asset value | 165.72B | 168.38B | 163.58B | 146.22B | 144.15B | |
Net current asset value | 32.59B | 40.33B | 25.53B | -9.65B | -13.25B | |
Invested capital | 0.19 | 0.29 | 0.24 | 0.32 | 0.54 | |
Average receivables | 172.19B | 159.82B | 153.16B | 152.68B | 161.3B | |
Average payables | 147.16B | 146.47B | 148.22B | 152.36B | 147.99B | |
Average inventory | 86.26B | 96.69B | 105.88B | 100.8B | 104.46B | |
Days sales outstanding | 88.25 | 83.06 | 77.61 | 79.03 | 83.53 | |
Days payables outstanding | 105.1 | 97.88 | 102.58 | 97.89 | 97.1 | |
Days of inventory on hand | 59.07 | 74.63 | 68.65 | 64 | 73.84 | |
Receivables turnover | 4.14 | 4.39 | 4.7 | 4.62 | 4.37 | |
Payables turnover | 3.47 | 3.73 | 3.56 | 3.73 | 3.76 | |
Inventory turnover | 6.18 | 4.89 | 5.32 | 5.7 | 4.94 | |
ROE | -0.06 | 0.04 | -0.09 | -0.1 | 0.03 | |
Capex per share | -95.15 | -196.17 | -369.21 | -1.16K | -657.16 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 11.77K | 13.12K | 12.3K | 12.16K | 12.33K | |
Net income per share | -288.18 | 872 | -93 | -282.14 | -153.53 | |
Operating cash flow per share | -533.43 | -741.25 | 582.22 | -1.14K | 958.96 | |
Free cash flow per share | -712.26 | -965.74 | 447.3 | -1.26K | 785.94 | |
Cash per share | 2.17K | 1.76K | 3.14K | 2.5K | 2.45K | |
Book value per share | 10.84K | 11.66K | 11.61K | 11.28K | 10.88K | |
Tangible book value per share | 10.03K | 10.9K | 10.77K | 10.36K | 9.89K | |
Share holders equity per share | 10.84K | 11.66K | 11.61K | 11.28K | 10.88K | |
Interest debt per share | 3.53K | 4.11K | 5.16K | 5.78K | 5.93K | |
Market cap | 324.22B | 269.78B | 272.95B | 239.26B | 258.21B | |
Enterprise value | 343.12B | 302.85B | 309.93B | 294.8B | 310.18B | |
P/E ratio | -19.3 | 5.31 | -50.56 | -14.55 | -28.85 | |
Price to sales ratio | 1.89 | 1.41 | 1.53 | 1.35 | 1.44 | |
POCF ratio | -41.71 | -24.98 | 32.31 | -14.41 | 18.48 | |
PFCF ratio | -31.24 | -19.18 | 42.05 | -12.98 | 22.55 | |
P/B Ratio | 2.05 | 1.59 | 1.62 | 1.46 | 1.63 | |
PTB ratio | 2.05 | 1.59 | 1.62 | 1.46 | 1.63 | |
EV to sales | 2 | 1.59 | 1.74 | 1.66 | 1.73 | |
Enterprise value over EBITDA | -130.33 | 16.24 | 545.35 | -601.45 | 277.43 | |
EV to operating cash flow | -44.14 | -28.05 | 36.69 | -17.75 | 22.2 | |
EV to free cash flow | -33.06 | -21.53 | 47.75 | -15.99 | 27.08 | |
Earnings yield | -0.01 | 0.05 | 0 | -0.02 | -0.01 | |
Free cash flow yield | -0.03 | -0.05 | 0.02 | -0.08 | 0.04 | |
Debt to equity | 0.32 | 0.34 | 0.43 | 0.5 | 0.54 | |
Debt to assets | 0.11 | 0.12 | 0.15 | 0.16 | 0.17 | |
Net debt to EBITDA | -7.18 | 1.77 | 65.07 | -113.31 | 46.49 | |
Current ratio | 1.09 | 1.13 | 1.03 | 1.01 | 1 | |
Interest coverage | -4.75 | 11.64 | -2.06 | -1.62 | -1.02 | |
Income quality | 1.85 | -0.74 | -4.82 | 3.59 | -6.25 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | -0.54 | 0 | 0 | |
Sales general and administrative to revenue | 0.05 | 0.04 | 0.05 | 0.05 | 0.05 | |
Research and developement to revenue | 0.05 | 0.05 | 0.07 | 0.06 | 0.07 | |
Intangibles to total assets | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | |
Capex to operating cash flow | 0.34 | 0.3 | -0.23 | 0.11 | -0.18 | |
Capex to revenue | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 | |
Capex to depreciation | -1.13 | -1.4 | -0.8 | -0.77 | -0.97 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 8.38K | 15.13K | 4.93K | 8.46K | 6.13K | |
ROIC | -0.02 | 0.07 | -0.02 | -0.01 | 0 | |
Return on tangible assets | -0.01 | 0.03 | 0 | -0.01 | 0 | |
Graham Net | -7.06K | -6.95K | -6.86K | -7.67K | -7.9K | |
Working capital | 22.98B | 36.47B | 8.33B | 4.81B | -1.12B | |
Tangible asset value | 146.22B | 158.84B | 156.29B | 150.94B | 144.15B | |
Net current asset value | -9.65B | 4.03B | 2.11B | -988.64M | -13.25B | |
Invested capital | 0.32 | 0.34 | 0.43 | 0.5 | 0.54 | |
Average receivables | 158.35B | 164.11B | 164.52B | 164.93B | 169.46B | |
Average payables | 155.03B | 152.57B | 149.69B | 152.21B | 151.44B | |
Average inventory | 100.19B | 107.6B | 115.88B | 120.85B | 117.88B | |
Days sales outstanding | 82.09 | 80.96 | 79.26 | 87.7 | 83.27 | |
Days payables outstanding | 101.31 | 103.86 | 96.01 | 104.18 | 95.79 | |
Days of inventory on hand | 66.24 | 78.52 | 76.16 | 82.79 | 72.85 | |
Receivables turnover | 1.1 | 1.11 | 1.14 | 1.03 | 1.08 | |
Payables turnover | 0.89 | 0.87 | 0.94 | 0.86 | 0.94 | |
Inventory turnover | 1.36 | 1.15 | 1.18 | 1.09 | 1.24 | |
ROE | -0.03 | 0.07 | -0.01 | -0.03 | -0.01 | |
Capex per share | -178.83 | -224.49 | -134.91 | -125.37 | -173.02 |
271980.KS Frequently Asked Questions
What is Jeil Pharmaceutical Co.,Ltd stock symbol ?
Jeil Pharmaceutical Co.,Ltd is a KR stock and trading under the symbol 271980.KS
What is Jeil Pharmaceutical Co.,Ltd stock quote today ?
Jeil Pharmaceutical Co.,Ltd stock price is $16700 today.
Is Jeil Pharmaceutical Co.,Ltd stock public?
Yes, Jeil Pharmaceutical Co.,Ltd is a publicly traded company.